Check Out What Whales Are Doing With MRNA
Portfolio Pulse from Benzinga Insights
Deep-pocketed investors are showing a bullish sentiment towards Moderna (NASDAQ:MRNA), with significant options activity indicating potential price movements. The focus is on a price range between $75 and $170. Analysts have mixed views, with target prices around $85.
September 10, 2024 | 4:16 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Significant options activity suggests bullish sentiment among large investors for Moderna, with a focus on a price range between $75 and $170. Analysts have set target prices around $85, indicating potential upward movement.
The article highlights significant options activity for Moderna, with a majority of investors showing a bullish sentiment. This suggests potential upward price movement. Analysts' target prices around $85 further support this outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100